» Articles » PMID: 37268351

Attaching and Effacing Pathogens Modulate Host Mitochondrial Structure and Function

Overview
Publisher Elsevier
Date 2023 Jun 2
PMID 37268351
Authors
Affiliations
Soon will be listed here.
Abstract

Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) are human enteric pathogens that contribute significantly to morbidity and mortality worldwide. These extracellular pathogens attach intimately to intestinal epithelial cells and cause signature lesions by effacing the brush border microvilli, a property they share with other "attaching and effacing" (A/E) bacteria, including the murine pathogen Citrobacter rodentium. A/E pathogens use a specialized apparatus called a type III secretion system (T3SS) to deliver specific proteins directly into the host cytosol and modify host cell behavior. The T3SS is essential for colonization and pathogenesis, and mutants lacking this apparatus fail to cause disease. Thus, deciphering effector-induced host cell modifications is critical for understanding A/E bacterial pathogenesis. Several of the ∼20-45 effector proteins delivered into the host cell modify disparate mitochondrial properties, some via direct interactions with the mitochondria and/or mitochondrial proteins. In vitro studies have uncovered the mechanistic basis for the actions of some of these effectors, including their mitochondrial targeting, interaction partners, and consequent impacts on mitochondrial morphology, oxidative phosphorylation and ROS production, disruption of membrane potential, and intrinsic apoptosis. In vivo studies, mostly relying on the C. rodentium/mouse model, have been used to validate a subset of the in vitro observations; additionally, animal studies reveal broad changes to intestinal physiology that are likely accompanied by mitochondrial alterations, but the mechanistic underpinnings remain undefined. This chapter provides an overview of A/E pathogen-induced host alterations and pathogenesis, specifically focusing on mitochondria-targeted effects.

Citing Articles

Mechanisms of Keap1/Nrf2 modulation in bacterial infections: implications in persistence and clearance.

Romero-Duran M, Silva-Garcia O, Perez-Aguilar J, Baizabal-Aguirre V Front Immunol. 2025; 15:1508787.

PMID: 39763664 PMC: 11700987. DOI: 10.3389/fimmu.2024.1508787.


Incidence and Clinical Course of Post-infectious Irritable Bowel Syndrome in Patients Admitted to University Hospitals: 1-year Prospective Follow-up Study.

Lee J, Lee S, Jang H, Kae S, Shin W, Seo S J Neurogastroenterol Motil. 2024; 31(1):110-118.

PMID: 39694067 PMC: 11735206. DOI: 10.5056/jnm24018.


Type III Secretion System in Intestinal Pathogens and Metabolic Diseases.

Zhou L, Zhang Y, Wu S, Kuang Y, Jiang P, Zhu X J Diabetes Res. 2024; 2024:4864639.

PMID: 39544522 PMC: 11561183. DOI: 10.1155/2024/4864639.


Diversity, Distribution and Structural Prediction of the Pathogenic Bacterial Effectors EspN and EspS.

Li Z, Hu Y, Song Y, Li D, Yang X, Zhang L Genes (Basel). 2024; 15(10).

PMID: 39457374 PMC: 11507257. DOI: 10.3390/genes15101250.

References
1.
James D, Parone P, Mattenberger Y, Martinou J . hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem. 2003; 278(38):36373-9. DOI: 10.1074/jbc.M303758200. View

2.
Crane J, Naeher T, Choudhari S, Giroux E . Two pathways for ATP release from host cells in enteropathogenic Escherichia coli infection. Am J Physiol Gastrointest Liver Physiol. 2005; 289(3):G407-17. DOI: 10.1152/ajpgi.00137.2005. View

3.
Crane J, Majumdar S, Pickhardt 3rd D . Host cell death due to enteropathogenic Escherichia coli has features of apoptosis. Infect Immun. 1999; 67(5):2575-84. PMC: 116006. DOI: 10.1128/IAI.67.5.2575-2584.1999. View

4.
Li Y, Zhu Y, Chu B, Liu N, Chen S, Wang J . Map of Enteropathogenic Targets Mitochondria and Triggers DRP-1-Mediated Mitochondrial Fission and Cell Apoptosis in Bovine Mastitis. Int J Mol Sci. 2022; 23(9). PMC: 9105652. DOI: 10.3390/ijms23094907. View

5.
Alto N, Shao F, Lazar C, Brost R, Chua G, Mattoo S . Identification of a bacterial type III effector family with G protein mimicry functions. Cell. 2006; 124(1):133-45. DOI: 10.1016/j.cell.2005.10.031. View